Annual Interest Expense
$3.87 M
+$1.39 M+56.35%
31 December 2023
Summary:
Heron Therapeutics annual interest expense is currently $3.87 million, with the most recent change of +$1.39 million (+56.35%) on 31 December 2023. During the last 3 years, it has risen by +$1.97 million (+103.47%). HRTX annual interest expense is now -1.75% below its all-time high of $3.94 million, reached on 31 December 2017.HRTX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
N/A
30 September 2024
Summary:
Heron Therapeutics quarterly interest expense is not available.HRTX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
N/A
30 September 2024
Summary:
Heron Therapeutics TTM interest expense is not available.HRTX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +56.4% | - | - |
| 3 y3 years | +103.5% | - | - |
| 5 y5 years | +44.8% | - | - |
HRTX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +103.5% | ||||
| 5 y | 5 years | at high | +162.8% | ||||
| alltime | all time | -1.8% | >+9999.0% |
Heron Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $3.87 M(+56.3%) | - | - |
| Dec 2022 | $2.47 M(+2.7%) | - | - |
| Dec 2021 | $2.41 M(+26.8%) | - | - |
| Dec 2020 | $1.90 M(+29.1%) | - | - |
| Dec 2019 | $1.47 M(-44.9%) | - | - |
| Dec 2018 | $2.67 M(-32.1%) | - | - |
| Dec 2017 | $3.94 M(+47.8%) | - | - |
| Dec 2016 | $2.66 M(+178.1%) | $1.60 M(+105.9%) | $2.66 M(+149.4%) |
| Sept 2016 | - | $775.00 K(+384.4%) | $1.07 M(+264.5%) |
| June 2016 | - | $160.00 K(+20.3%) | $293.00 K(+29.6%) |
| Mar 2016 | - | $133.00 K(+43.0%) | $226.00 K(-25.4%) |
| Dec 2015 | $958.00 K | - | - |
| June 2015 | - | $93.00 K(-55.7%) | $303.00 K(+44.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $210.00 K(-2.8%) | $210.00 K(-75.1%) |
| Dec 2014 | $887.00 K(+7.1%) | - | - |
| Mar 2014 | - | $216.00 K(+0.9%) | $843.00 K(+1.8%) |
| Dec 2013 | $828.00 K(+36.9%) | $214.00 K(+2.4%) | $828.00 K(+1.3%) |
| Sept 2013 | - | $209.00 K(+2.5%) | $817.00 K(+1.7%) |
| June 2013 | - | $204.00 K(+1.5%) | $803.00 K(+7.8%) |
| Mar 2013 | - | $201.00 K(-1.0%) | $745.00 K(+23.1%) |
| Dec 2012 | $605.00 K(+62.2%) | $203.00 K(+4.1%) | $605.00 K(+50.5%) |
| Sept 2012 | - | $195.00 K(+33.6%) | $402.00 K(+94.2%) |
| June 2012 | - | $146.00 K(+139.3%) | $207.00 K(+239.3%) |
| Mar 2012 | - | $61.00 K(>+9900.0%) | $61.00 K(+6000.0%) |
| Dec 2011 | $373.00 K(>+9900.0%) | - | - |
| Dec 2010 | $2000.00 | $0.00(-100.0%) | $1000.00(0.0%) |
| Sept 2010 | - | $1000.00 | $1000.00 |
FAQ
- What is Heron Therapeutics annual interest expense?
- What is the all time high annual interest expense for Heron Therapeutics?
- What is Heron Therapeutics annual interest expense year-on-year change?
- What is the all time high quarterly interest expense for Heron Therapeutics?
- What is the all time high TTM interest expense for Heron Therapeutics?
What is Heron Therapeutics annual interest expense?
The current annual interest expense of HRTX is $3.87 M
What is the all time high annual interest expense for Heron Therapeutics?
Heron Therapeutics all-time high annual interest expense is $3.94 M
What is Heron Therapeutics annual interest expense year-on-year change?
Over the past year, HRTX annual interest expense has changed by +$1.39 M (+56.35%)
What is the all time high quarterly interest expense for Heron Therapeutics?
Heron Therapeutics all-time high quarterly interest expense is $1.60 M
What is the all time high TTM interest expense for Heron Therapeutics?
Heron Therapeutics all-time high TTM interest expense is $2.66 M